Scholars@Duke publication: Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.

Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.

Publication , Journal Article

Xian, Y; Xu, H; Smith, EE; Fonarow, GC; Bhatt, DL; Schwamm, LH; Peterson, ED

Published in: JAMA Intern Med

May 1, 2022

This cohort study examines patterns in prescriptions of dual antiplatelet therapy after publication of important trials and release of updated guidelines.

Duke Scholars

Author Ying Xian Neurology, Neurocritical Care

Author Haolin Xu

Altmetric Attention Stats

Dimensions Citation Stats

Published In

JAMA Intern Med

DOI

10.1001/jamainternmed.2022.0323

EISSN

2168-6114

Publication Date

May 1, 2022

Volume

182

Issue

Start / End Page

559 / 564

Location

United States

Related Subject Headings

Stroke
Secondary Prevention
Platelet Aggregation Inhibitors
Ischemic Stroke
Ischemic Attack, Transient
Humans
Drug Therapy, Combination
Clopidogrel
Aspirin
4203 Health services and systems

Citation

APA

Chicago

ICMJE

MLA

NLM

Xian, Y., Xu, H., Smith, E. E., Fonarow, G. C., Bhatt, D. L., Schwamm, L. H., & Peterson, E. D. (2022). Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. JAMA Intern Med, 182(5), 559–564. https://doi.org/10.1001/jamainternmed.2022.0323

Xian, Ying, Haolin Xu, Eric E. Smith, Gregg C. Fonarow, Deepak L. Bhatt, Lee H. Schwamm, and Eric D. Peterson. “Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.” JAMA Intern Med 182, no. 5 (May 1, 2022): 559–64. https://doi.org/10.1001/jamainternmed.2022.0323.

Xian Y, Xu H, Smith EE, Fonarow GC, Bhatt DL, Schwamm LH, et al. Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. JAMA Intern Med. 2022 May 1;182(5):559–64.

Xian, Ying, et al. “Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.” JAMA Intern Med, vol. 182, no. 5, May 2022, pp. 559–64. Pubmed, doi:10.1001/jamainternmed.2022.0323.

Xian Y, Xu H, Smith EE, Fonarow GC, Bhatt DL, Schwamm LH, Peterson ED. Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. JAMA Intern Med. 2022 May 1;182(5):559–564.